










































Microtubule nucleation properties of single human TuRCs
explained by their Cryo-EM structure
Citation for published version:
Consolati, T, Locke, J, Roostalu, J, Chen, ZA, Gannon, J, Asthana, J, Lim, WM, Martino, F, Cvetkovic, MA,
Rappsilber, J, Costa, A & Surrey, T 2020, 'Microtubule nucleation properties of single human TuRCs
explained by their Cryo-EM structure', Developmental Cell, vol. 53, no. 5, pp. 603-617.e8.
https://doi.org/10.1016/j.devcel.2020.04.019
Digital Object Identifier (DOI):
10.1016/j.devcel.2020.04.019
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:




Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 31. Jul. 2020
Article
Microtubule Nucleation Properties of Single Human
gTuRCs Explained by Their Cryo-EM StructureGraphical AbstractHighlightsd The g-tubulin ring complex (gTuRC) nucleates microtubules
and caps their minus ends
d Microtubule nucleation from purified gTuRC is highly
cooperative, yet inefficient
d A partly open, asymmetric structure of gTuRC explains
inefficient nucleation
d Actin and MZT2 stabilize the closed part of the gTuRC
structureConsolati et al., 2020, Developmental Cell 53, 603–617
June 8, 2020 ª 2020 The Author(s). Published by Elsevier Inc.
https://doi.org/10.1016/j.devcel.2020.04.019Authors
Tanja Consolati, Julia Locke,
Johanna Roostalu, ..., Juri Rappsilber,





Consolati et al. find that microtubule
nucleation by individual gTuRC
complexes is inefficient despite its
proposed role as a nucleating template. A
4 A˚ structure of the complex reveals a
mismatch with the microtubule structure,
explaining the inefficiency of nucleation
and providing a possible mechanism for
the regulation of nucleation.ll
OPEN ACCESS
llArticle
Microtubule Nucleation Properties of Single Human
gTuRCs Explained by Their Cryo-EM Structure
Tanja Consolati,1,2,6 Julia Locke,1,6 Johanna Roostalu,1,7 Zhuo Angel Chen,3,4 Julian Gannon,1 Jayant Asthana,1,2
Wei Ming Lim,1,2 Fabrizio Martino,1 Milos A. Cvetkovic,1 Juri Rappsilber,3,4 Alessandro Costa,1,*
and Thomas Surrey1,2,5,8,*
1The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK
2Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Dr Aiguader 88, 08003 Barcelona, Spain
3Bioanalytics, Institute of Biotechnology, Technische Universit€at Berlin, Berlin, Germany
4Wellcome Centre for Cell Biology, University of Edinburgh, Edinburgh, UK
5ICREA, Passeig de Lluis Companys 23, 08010 Barcelona, Spain
6These authors contributed equally
7Present address: The Wellcome Trust, London, United Kingdom
8Lead Contact
*Correspondence: alessandro.costa@crick.ac.uk (A.C.), thomas.surrey@crg.eu (T.S.)
https://doi.org/10.1016/j.devcel.2020.04.019SUMMARYThe g-tubulin ring complex (gTuRC) is the major microtubule nucleator in cells. The mechanism of its regu-
lation is not understood. We purified human gTuRC and measured its nucleation properties in a total internal
reflection fluorescence (TIRF) microscopy-based real-time nucleation assay. We find that gTuRC stably caps
the minus ends of microtubules that it nucleates stochastically. Nucleation is inefficient compared with
microtubule elongation. The 4 A˚ resolution cryoelectron microscopy (cryo-EM) structure of gTuRC, com-
bined with crosslinking mass spectrometry analysis, reveals an asymmetric conformation with only part of
the complex in a ‘‘closed’’ conformation matching the microtubule geometry. Actin in the core of the
complex, and MZT2 at the outer perimeter of the closed part of gTuRC appear to stabilize the closed confor-
mation. The opposite side of gTuRC is in an ‘‘open,’’ nucleation-incompetent conformation, leading to a
structural asymmetry explaining the low nucleation efficiency of purified human gTuRC. Our data suggest
possible regulatory mechanisms for microtubule nucleation by gTuRC closure.INTRODUCTION
Microtubule nucleation in cells is spatially and temporally
controlled to ensure proper cytoskeleton function. The major
nucleator is the g-tubulin ring complex (gTuRC) in which several
g-tubulin complex proteins (GCPs) arrange 14 g-tubulins into a
helical arrangement so that they can serve as a template for
microtubule nucleation (Kollman et al., 2011; Tovey and Conduit,
2018). The structure of gTuRC is best understood in budding
yeast where 7 smaller ‘‘Y-shaped’’ gTuSC complexes, each con-
sisting of 2 g-tubulins and one copy of GCP2 and GCP3,
assemble into a conically shaped assembly upon recruitment
to the spindle pole body by Spc110 (Kollman et al., 2010). A cry-
oelectronmicroscopy (cryo-EM) reconstruction of budding yeast
gTuSC in complex with a Spc110 fragment at 8-A˚ resolution re-
vealed gaps between every second g-tubulin in gTuRC creating
a mismatch with the microtubule structure (Kollman et al., 2015).
Microtubule nucleation by budding yeast gTuRC in this ‘‘open’’
conformation could be improved 2–3-fold by artificially closing
these gaps through chemical crosslinking, suggesting a possible
mechanism for activation of nucleation by budding yeast gTuRC
(Kollman et al., 2015).Developmental Cell 53, 603–617,
This is an open access article undIn fission yeast, filamentous fungi, and metazoans, some
GCP2s and GCP3s are replaced in the complex by additional
GCP4, GCP5, and GCP6 proteins and in metazoans gTuRC is
a stable complex whose assembly is independent of the recruit-
ment to target structures, such as centrosomes (Farache et al.,
2018; Lin et al., 2015; Murphy et al., 2001; Oegema et al.,
1999; Tovey and Conduit, 2018). The exact stoichiometry and
subunit order of human gTuRC is not known. Several proteins
have been implicated in activating gTuRC, among which are
MZT1 andMZT2, also sometimes classified as core components
of the metazoan complex (Hutchins et al., 2010; Kollman et al.,
2011; Lin et al., 2016; Teixido´-Travesa et al., 2012), the recruit-
ment factors CDK5Rap2 (functional homolog of budding yeast
Spc110) (Choi et al., 2010; Lin et al., 2014; Muroyama et al.,
2016) and NEDD1 (Scrofani et al., 2015), or microtubule dy-
namics regulators, such as the microtubule polymerase chTOG
(XMAP215) or the multifunctional, catastrophe-suppressing pro-
tein TPX2 (Alfaro-Aco et al., 2017; Popov et al., 2002; Scrofani
et al., 2015; Thawani et al., 2018).
A clear understanding of the mechanisms by which the effi-
ciency of microtubule nucleation by human gTuRC is regulated
is however lacking. The kinetics of microtubule nucleation eitherJune 8, 2020 ª 2020 The Author(s). Published by Elsevier Inc. 603
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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measured either by following the turbidity of suspensions of nucle-
ating microtubules over time or by fluorescence microscopy im-
aging of microtubules at distinct times after mixing gTuRC with
tubulin (Oegema et al., 1999; Voter and Erickson, 1984). Both
types of assays have disadvantages, as they cannot distinguish
easily between gTuRC-mediated and spontaneous microtubule
nucleation and between microtubule nucleation and effects pro-
duced by microtubule growth and/or dynamic instability.
To overcome these limitations, we developed a microscopy-
based in vitronucleationassay thatallows the real-timeobservation
of thenucleationof individualmicrotubulesbysinglesurface-immo-
bilized human gTuRCs, and we studied the structure of the gTuRC
complex by cryo-EM combined with crosslinking mass spectrom-
etry (CLMS). We found that human gTuRC-mediated nucleation is
stochastic, highly cooperative, and faces a significant kinetic bar-
rier. gTuRC improved the nucleation efficiency compared with
spontaneous microtubule nucleation, but templated nucleation
was still less efficient than microtubule plus-end elongation. A 4-A˚
resolution structure of human gTuRC revealed several features
that are distinctly different from the structure of budding yeast
gTuRC; surprisingly, gTuRC harbors actin in its central core and
thecomplex ismarkedly asymmetriconly partiallymatching thege-
ometry of the active form of yeast gTuRC. Our results provide an
explanation for theobservedkineticbarrier for nucleationbyhuman
gTuRC and suggest a possible stimulatory function of additional
factors that would morph gTuRC into a fully activated form.
RESULTS
Purification of Biotinylated Human gTuRC
We generated a HeLa Kyoto cell line that expressed a biotin
acceptor peptide (BAP) and monomeric blue fluorescence pro-
tein (mBFP)-tagged GCP2 from a randomly integrated gene.
Tagged GCP2 became incorporated into the human gTuRC
complex and was biotinylated without compromising gTuRC
function as indicated by the correct localization of the fluores-
cent complex to centrosomes and normal cell growth. We puri-
fied  0.1 mg tagged gTuRC from 120 g of cells in a one-day
procedure using anion exchange, biotin affinity, and size exclu-
sion chromatography (STAR Methods) (Figures 1A, 1B, and S1).
Using mass spectroscopy, we identified all human gTuRC
core subunits (g-tubulin, GCP2-6), as well as MZT1, MZT2,
and actin, which were co-purified in previous gTuRC purifica-
tions (Figure S1C; Data S1) (Choi et al., 2010; Hutchins et al.,
2010; Oegema et al., 1999; Teixido´-Travesa et al., 2012; Thawani
et al., 2018). Additionally, we verifiedmost subunits also bywest-
ern blot using specific antibodies (Figure 1C; see also Fig-
ure S1B), indicating that the human gTuRC complex was suc-
cessfully purified using our biotin affinity purification strategy.
Purified gTuRC appeared as the typical characteristic ‘‘rings’’
with25-nm diameter in negative-stain electron microscopy im-
ages (Figure 1D) (Zheng et al., 1995), confirming the presence of
properly assembled complexes.
gTuRC Nucleates Single Microtubules and Caps Their
Minus Ends
Next, we set up amicroscopy-based real-time gTuRC-mediated
microtubule nucleation assay (Figure 1E). We used NeutrAvidin604 Developmental Cell 53, 603–617, June 8, 2020to immobilize purified biotinylated gTuRC on a biotin-polyeth-
ylene glycol (PEG)-functionalized glass surface. Specific
immobilization of biotinylated and mBFP-tagged gTuRC could
be verified by measuring the mBFP fluorescence on NeutrAvidin
surfaces and on surfaces lacking NeutrAvidin using total internal
reflection fluorescence (TIRF) microscopy (Figures 1F and S2A).
In the presence of CF640R-labeled tubulin, microtubules
nucleated from the gTuRC-coated surface, whereas hardly any
microtubules nucleated in the absence of gTuRC under these
conditions (Figures 1F and 1G).
Only one end of gTuRC-nucleated microtubules grew,
whereas the other was tethered to the surface likely via gTuRC
(Figures 2A, top rows, and 2B, left; Video S1). In contrast,
when microtubules elongated from surface-immobilized, stabi-
lized microtubule ‘‘seeds’’ in control experiments, both microtu-
bule ends grew (Figures 2A, bottom row, and 2B, right) with the
faster plus-end growth speed of 26.8 ± 0.4 nm/s essentially
equating the growth speed of gTuRC-nucleated microtubules
of 26.3 ± 0.4 nm/s (errors are SEM) (Figure 2C, top). This obser-
vation demonstrates that gTuRC-nucleated microtubules grow
exclusively at their plus end. Minus ends grew from ‘‘seeds’’
with a speed of 7.0 ± 0.2 nm/s, whereas surface-anchoredminus
ends of gTuRC-nucleated microtubules did not grow (Figure 2C,
bottom). mGFP-labeled growing microtubule end marker EB3
decorated only the growing plus ends of gTuRC-nucleated mi-
crotubules (Figures 2D and 2E; Video S2), similar to the situation
in the cell (Akhmanova and Steinmetz, 2015). In rare cases,
gTuRC-nucleated microtubules first grew out of the TIRF field
and later, remaining gTuRC-anchored, aligned with the surface
only growing with one end (Figures S2Bi and S2Bii). These
data clearly demonstrate that, at our experimental conditions,
plus ends of gTuRC-nucleated microtubules are dynamic and
minus ends are capped by gTuRC. The occasional microtubule
that nucleated in solution and then landed on the glass surface
was easily distinguished from gTuRC-nucleated microtubules,
as it became suddenly visible as an already elongated microtu-
bule, displaying two dynamic microtubule ends and often also
diffusing along the surface (Figures S2Biii and S2Biv).
Imaging the mBFP fluorescence of single immobilized gTuRC
complexes at a reduced gTuRC density revealed that all surface-
nucleated microtubules originated from a mBFP-labeled gTuRC
(Figures 2F and 2G; VideoS3). Taken together, these data demon-
strate that immobilized gTuRC stimulates microtubule nucleation,
generatingmicrotubules with a cappedminus and a dynamic plus
end. We did not observe microtubule detachment from immobi-
lizedgTuRC, indicating thatgTuRC isstablybound to its nucleated
microtubule within the entire duration of our experiments (20 min).
gTuRC-Mediated Microtubule Nucleation Is Stochastic,
Cooperative, and Not Very Efficient
Next, we quantified the number ofgTuRC-nucleatedmicrotubules
per field of view, excluding the small fraction of microtubules
nucleated in solution. Counting the gTuRC-nucleated
microtubules, showed a linear increase of their number with
time (Figures 3A and 3Bi; Video S4). This demonstrates that
gTuRC-mediated nucleation is a stochastic processwith constant
nucleation probability. Increasing the gTuRC density on the sur-
face while keeping the tubulin concentration constant at 15 mM,
demonstrated that the overall nucleation rate (increase of
Figure 1. Purification and Characterization of gTuRC-mBFP-BAP
(A) Overview of purification steps.
(B) Coomassie-stained SDS-PAGE of purified gTuRC. Protein bands corresponding to gTuRC subunits as identified by mass spectrometry are labeled.
(C)Western blots of purified gTuRC using antibodies against g-tubulin, GCP2, GCP4, actin, andmBFP. Biotinylation of the BAPwas assessed by immunoblotting
using horse radish peroxidase (HRP)-coupled streptavidin.
(D) Negative-stain electron microscopy of purified gTuRC showing the expected 25-nm diameter ring structures. Two examples (white arrows) are shown as
insets at higher magnification.
(E) Schematic of TIRFM-based real-time gTuRC nucleation assay. Biotinylated fluorescent gTuRC is immobilized on a biotin-PEG-functionalized glass surface via
NeutrAvidin. ab-tubulin is added to initiate microtubule nucleation by immobilized gTuRC.
(F) Representative TIRFM images showing the mBFP channel to visualize gTuRC on the surface (left panel) and showing the CF640R-tubulin channel to visualize
nucleated microtubules (right panel) at t = 20min after start of microtubule nucleation by a temperature jump to 33C. 373 pM gTuRCwas used for immobilization
and the final CF640R-tubulin concentration was 15 mM. A representative control at 15 mMCF640R-tubulin without gTuRC is also shown. Intensities in the images
are directly comparable.
(G) Bar graph of the average microtubule number nucleated by surface-immobilized gTuRC (373 pM used for immobilization) within 15 min in presence of 15 mM
CF640R-tubulin (n = 3). Error bars are SD. Scale bars as indicated. t = 0 is 2 min after placing the sample at 33C. See also Figures S1 and S2A.
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Figure 2. gTuRC Nucleates and Caps Microtubules at Their Minus End
(A–C) Comparison between gTuRC microtubule nucleation assay and microtubule seed assay. Both assays were performed in the presence of 15 mM CF640R-
tubulin. For gTuRC microtubule nucleation assay 373 pM gTuRC were used for immobilization. (A) Representative time series of individual microtubules (2 top
rows of panels) nucleated on a gTuRC surface showing a static (purple arrow) and a fast-growingmicrotubule end. A control without gTuRC (bottom row) shows a
microtubule growing from a stabilized microtubule ‘‘seed,’’ displaying two growing microtubule ends with the minus end (purple arrow) growing more slowly than
the plus end. (B) Representative TIRFM kymographs of microtubules nucleated by surface-immobilized gTuRC. For comparison a kymograph of a microtubule
grown from a microtubule seed at the same tubulin concentration is shown. (C) Box-and-whiskers plots of microtubule plus-end (top) and minus-end (bottom)
growth speeds for gTuRC nucleation assays and microtubule seed assays.
(D and E) mGFP-EB3 tracks the growing plus end of gTuRC nucleated microtubules. Assays were performed in the presence of 12.5 mM CF640R-tubulin and
200 nM mGFP-EB3 using 373 pM gTuRC for immobilization. Data were pooled from two independent experiments. Number of microtubule growth speeds
measured per conditions: gTuRC nucleation assay, plus-end growth: n = 86,minus-end growth: n = 71;microtubule seed assay, plus-end growth: n = 110,minus-
end growth: n = 123. For the box-and-whiskers plots, boxes range from 25th to 75th percentile, the whiskers span from 10th to 90th percentile, and the horizontal
line marks the mean value. (D) Representative time series of merged TIRFM images of two individual microtubules (magenta) nucleated from a gTuRC surface.
mGFP-EB3 (green, white arrow) tracks the growing microtubule plus end, while the microtubule minus end is static. (E) Corresponding TIRFM kymographs.
(F and G) Microtubules are nucleated by single gTuRC molecules. Assays were performed in the presence of 20 mM CF640R-tubulin using 27 pM gTuRC for
immobilization. (F) Representative time series of merged TIRFM images showing individual microtubules (magenta) nucleated from single immobilized gTuRC
molecules (cyan, white arrow). (G) Corresponding TIRFM kymographs. All experiments were performed at 33C. Scale bars as indicated. t = 0 is 2 min after
placing the sample at 33C. See also Figure S2B; Videos S1–S3.
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Figure 3. The Microtubule Nucleation Efficiency of gTuRC Depends on gTuRC Surface Density and Tubulin Concentration
(A and B) Microtubule nucleation at 33C in the presence of 15 mMCF640R-tubulin at varying gTuRC concentrations used for immobilization (23, 47, 93, 187, 249,
and 373 pM). (A) Representative time series of TIRFM images at the indicated gTuRC concentrations (top panel). For comparison, spontaneous microtubule
nucleation in the absence of gTuRC at the same tubulin concentration is shown (bottom panel). (B) Plots showing (i) a linear increase in microtubule number over
time, (ii) themean gTuRC surface density (mBFP fluorescence in the field of view), (iii) themeanmicrotubule plus-end growth speed, and (iv) themeanmicrotubule
nucleation rate (bottom right) at different gTuRC concentrations. Number ofmicrotubule growth speedsmeasured per conditions: 23 pM, n = 27; 47 pM, n = 64; 93
pM, n = 96; 187 pM, n = 191; 249 pM, n = 160; 373 pM, n = 302.
(C and D) Microtubule nucleation in presence of 373 pM gTuRC used for immobilization at varying CF640R-tubulin concentrations (7.5, 10, 12.5, 15, 18, and
20 mM). (C) Representative time series of TIRFM images of microtubule nucleation in the presence of the indicated CF640R-tubulin concentrations (top panel). For
comparison, spontaneous microtubule nucleation in the absence of gTuRC is shown for the highest tested tubulin concentration (20 mM) (bottom panel).
Spontaneous microtubule nucleation was always much less than gTuRC-mediated nucleation comparing the same tubulin concentrations (not shown). (D) Plots
showing (i) the linear increase in microtubule number over time, (ii) the mean gTuRC surface density (mBFP fluorescence in the field of view), (iii) the mean
microtubule plus-end growth speed, and (iv) the mean microtubule nucleation rate at different tubulin concentrations. Arrows mark the critical tubulin con-
centration for microtubule elongation (gray) defined as the intercept of the fit in Figure 3Diii with the x axis and the minimal concentration required for gTuRC-
mediated nucleation (purple) and for spontaneous nucleation in the absence of gTuRC (green) both defined empirically as the tubulin concentration at which on
average 1 or moremicrotubules become visible within 20min in the field of view (1643 164 mm). Number of microtubule growth speedsmeasured per conditions:
7.5 mM, n = 9; 10 mM, n = 51; 12.5 mM, n = 210; 15 mM, n = 190; 18 mM, n = 237; 20 mM, n = 244. Data for plots were pooled from at least three independent
experiments. The plot of the nucleation rate against tubulin concentration (see Figure 3Div) was fit using a power law function. All other lines represent a linear
(legend continued on next page)
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the gTuRC concentration used for gTuRC surface immobilization
(Figures 3A and 3Bii; Video S4) and with the measured mBFP in-
tensity at the surface, i.e., the gTuRC density (Figure 3Biv). The
microtubule growth speed was unaffected by the gTuRC density
(Figure 3Biii), in agreement with the tubulin concentration essen-
tially remaining unchanged in these experiments. We conclude
that gTuRC stimulates nucleation in a dose-dependent manner.
Next, we changed the tubulin concentration keeping the
gTuRC density constant (Figures 3C and 3Dii; Video S5). While
the microtubule growth speed increased linearly with tubulin
concentration, as expected (Figure 3Diii), the nucleation rate
increased very non-linearly with tubulin concentration (Figures
3C, 3Di, and 3Div), in agreement with an early study using Xen-
opus gTuRC (Zheng et al., 1995). A fit to the gTuRC-mediated
dependence of the nucleation rate on the tubulin concentration
using a power law (line in Figure 3Div) yielded an exponent of
6.7, demonstrating that gTuRC-mediated nucleation is a highly
cooperative process, similar to spontaneous nucleation in solu-
tion (Erickson and Pantaloni, 1981; Kuchnir Fygenson et al.,
1995; Voter and Erickson, 1984); however, gTuRC-mediated
nucleation is clearly more efficient than spontaneous nucleation
at all tubulin concentrations (Figure S2C). The fit to the power law
can also be used to provide an estimate for the minimal size of a
templated tubulin assembly on gTuRC that allows stable micro-
tubule outgrowth, which is in the range of one to two times the
value of the exponent (Kuchnir Fygenson et al., 1995; Voter
and Erickson, 1984). The minimal tubulin concentration required
for detectable gTuRC-mediated nucleation was 7.5 mM and
hence significantly lower than the 15 mM for spontaneous
nucleation in solution in the absence of gTuRC (Figure 3Div:
microtubule elongation [gray arrow], gTuRC-mediated nucle-
ation [purple arrow], and spontaneous nucleation [green arrow])
(Figure S2C) (Brouhard and Rice, 2018; Gard and Kirschner,
1987a; Roostalu and Surrey, 2017). However, gTuRC-mediated
nucleation required a tubulin concentration still higher than the
2 mM tubulin threshold above which pre-existing microtubule
plus ends elongate (Figure 3Diii) (Voter and Erickson, 1984;
Wieczorek et al., 2015). This indicates that templating a new
microtubule from gTuRC is easier than forming a new microtu-
bule in solution, but it is clearly less efficient compared with elon-
gating an existing growing microtubule end.
Comparing the number of gTuRC complexes on the surface as
measured by the number of mBFP dots with the number of
nucleation events at 20 mM tubulin revealed that only 0.5% of
complexes nucleated a microtubule within 9 min at our condi-
tions. Therefore, gTuRC-mediated microtubule nucleation
appears to be rather inefficient, suggesting that most likely addi-
tional factors are required for activating the complex or for pro-
moting nucleation by stabilizing a freshly nucleated nascent
microtubule. Therefore, using our nucleation assay we tested
the effects on human gTuRC-mediated microtubule nucleation
elicited by three proteins that are known to affect microtubule
dynamics by preferentially binding to microtubule endsregression. Nucleation rates (rnuc) were taken from the slope of the linear regressio
experiments were performed at 33C. All error bars are SEM. For symbols without
always 1643 164 mm. AU, arbitrary units. Fluorescence intensities are directly com
See also Figure S2C; Videos S4 and S5.
608 Developmental Cell 53, 603–617, June 8, 2020and that have also been reported to affect nucleation in different
ways.
chTOG and TPX2 Stimulate gTuRC-Mediated
Microtubule Nucleation
The microtubule polymerase chTOG/XMAP215 (Brouhard et al.,
2008; Gard and Kirschner, 1987b) is known to mildly stimulate
spontaneous microtubule nucleation in vitro (Ghosh et al.,
2013; Roostalu et al., 2015). In the presence of human chTOG,
nucleation from surface-immobilized gTuRC is strongly pro-
moted (Figures 4A–4C; Video S6), in agreement with previous re-
ports using the budding yeast and Xenopus orthologs of these
proteins (Gunzelmann et al., 2018; Thawani et al., 2018). We
find here that chTOG stimulates microtubule nucleation by hu-
man gTuRCby a factor of up to 21-fold (Figure 4C), with the stim-
ulatory effect saturating in a physiological concentration range
(100 nM in Xenopus egg extract; Kronja et al., 2009; Reber
et al., 2013; W€uhr et al., 2014). Saturation of the acceleration of
microtubule plus-end growth by chTOG occurs at a similar con-
centration (Figures 4D and S3), suggesting that both chTOG ef-
fects are related and saturate when plus-end-binding sites at
microtubule ends are fully occupied by chTOG. Thus, accelera-
tion of outgrowth of a nascent microtubule forming on gTuRC
may be one mechanism to increase overall nucleation efficiency
(Roostalu and Surrey, 2017).
TPX2, a protein involved in chromatin-dependent microtubule
nucleation, can also stimulate nucleation in vitro (Alfaro-Aco
et al., 2017; Roostalu et al., 2015; Schatz et al., 2003). We tested
here to which extent TPX2 could stimulate microtubule nucle-
ation from immobilized gTuRC. We measured microtubules
nucleating from the gTuRC surface, excluding the only minor
fraction of those microtubules that nucleate from local TPX2 ac-
cumulations possibly representing recently reported TPX2 con-
densates forming at high TPX2 concentrations (King and Petry,
2020) (Figure S4). We observed that TPX2 stimulated gTuRC-
mediated microtubule nucleation in a dose-dependent manner
(Figures 4E–4G; Video S7), however, only at rather high concen-
trations compared with physiological TPX2 concentrations (25–
100 nM in Xenopus egg extract; Gruss et al., 2001; Thawani
et al., 2019; W€uhr et al., 2014). TPX2 had no strong effect on
microtubule growth speed (Figure 4H), as reported previously
(Roostalu et al., 2015; Wieczorek et al., 2015). Therefore, TPX2
likely promotes gTuRC-mediated nucleation in vitro by a
different mechanism compared with chTOG, possibly by sup-
pressing depolymerization of a nascent microtubule on gTuRC,
through its catastrophe-suppressing activity (Roostalu et al.,
2015; Wieczorek et al., 2015). In contrast to chTOG and TPX2,
we did not observe any effect of the plus-end-tracking protein
EB3 on gTuRC-mediated nucleation (Figures 4I–4L).
The Cryo-EM Structure and CLMS Analysis of
Human gTuRC
To understand themolecular basis of microtubule nucleation, we
determined the cryo-EM structure of gTuRC to a resolution of 4 A˚n of the increase of microtubule number over time (see Figures 3Bi and 3Di). All
visible error bars, error bars are smaller than the symbol size. Field of view was
parable. Scale bars as indicated. t = 0 is 2min after placing the sample at 33C.
Figure 4. Microtubule Associated Proteins Can Increase the Microtubule Nucleation Efficiency of gTuRC
(A–D) gTuRC-mediated microtubule nucleation in the presence of different chTOG-mGFP concentrations (6, 13, 25, 50, and 100 nM). Assays were performed in
the presence of chTOG-mGFP and 10 mM CF640R-tubulin using 373 pM gTuRC for immobilization. (A) Representative TIRFM images of gTuRC-mediated
(legend continued on next page)
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2019; Figure S5; also see Table 1). The complex is arranged in
a left-handed spiral cone (reminiscent of a churros paper
wrap), narrowing at one end, with a 300-A˚ largest diameter and
a height of 200 A˚ (Figure 5A). The spiral is formed by 14 similar
modules (‘‘stalks’’), which support 14 globular features deco-
rating the largest face of the complex. Comparison with the crys-
tal structure of the GCP4 subunit of gTuRC (PDB:3RIP) (Guillet
et al., 2011) allows the immediate identification of 14 different
GCP protomers forming the spiral, which we number starting
from the narrow bottom to the large-face top of the spiral.
Notably, subunit 14 at the top of the spiral aligns with the lower-
most subunit 1 (Figure 5B). Inter-GCP interactions closely
resemble those observed at the GCP2-GCP3 interface visible
in the yeast gTuSC complex structure (Kollman et al., 2015).
While GCP subunits 1–8 in gTuRC engage in tight inter-protomer
interactions that involve both the constricted side and the larger
side of the cone, subunits 9–14 merely interact at the tip of the
cone and appear more flexible as they depart radially from the
core of the structure (Figure 5A). The globular densities deco-
rating the wider side of the GCP cone was rigid-body fitted by
14 g-tubulin protomers (PDB:1Z5W) (Aldaz et al., 2005), resulting
in a configuration akin to the gTuSC structure (Kollman et al.,
2015) (Figure 5B).
Although the local resolution of the g-tubulin subunits varies
around the ring, nucleotide density can clearly be observed
when the local resolution is high enough, for example, for g-
tubulin in position 11 (Figure 5C). Densities appear less defined
for g-tubulin in particular for positions 12, 13, and 14. Our reso-
lution does not allow discrimination between guanosine triphos-
phate (GTP) and guanosine diphosphate (GDP) in the active site.
GCP2-interacting g-tubulin from the N-terminal bottom of the
spiral appears engaged with the GCP3-interacting g-tubulin
pointing toward the C-terminal top of the spiral. Conversely,
gaps of varying extents can be identified between g-tubulins
engaged by other GCP subunits (Figure 5B). Due to limits in res-
olution, we cannot comment on differences in the configuration
of lateral loops in the g-tubulin subunits around the gTuRC spiral.
As our mass spectrometry analysis of the purified human
gTuRC identified all five paralogousGCP2, 3, 4, 5, and 6 subunits
(Figure S1C; Data S1), we sought to identify each subunit in ourmicrotubule nucleation in the presence of different chTOG-mGFP concentratio
showing, (B) linearly increasing microtubule numbers over time, (C) themeanmicro
chTOG-mGFP concentrations. Number ofmicrotubule growth speedsmeasured p
pM, n = 160; 373 pM, n = 302.
(E–H) gTuRC-mediated microtubule nucleation in the presence of different mGFP
presence of mGFP-TPX2 and 10 mMCF640R-tubulin using 373 pM gTuRC for imm
nucleation in the presence of mGFP-TPX2 concentrations (green), as indicated.
mean microtubule nucleation rate, and (H) the mean microtubule growth speed a
measured per conditions: 0 nM, n = 15; 49 nM, n = 50; 98 nM, n = 77; 195 nM, n
(I–L) gTuRC-mediated microtubule nucleation in the presence of different mGFP-
presence of mGFP-EB3 and 12.5 mM CF640R-tubulin using 373 pM gTuRC for
microtubule nucleation in the presence of different mGFP-EB3 concentrations (g
over time, (K) the mean microtubule nucleation rate, and (L) the mean microtubule
growth speeds measured per conditions: 0 nM, n = 210; 50 nM, n = 132; 100 nM,
images in either the absence of microtubule associated proteins or absence of gT
associated proteins. Lines represent the linear regression. Nucleation rates (rnuc) w
number over time (see Figures 4B, 4F, and 4J). All experiments were performed at
are smaller than the symbol size. Field of view was always 164 3 164 mm. AU, a
indicated. t = 0 is 2 min after placing the sample at 33C. See also Figures S3 an
610 Developmental Cell 53, 603–617, June 8, 202014-mer complex. We first generated homology models for hu-
man GCP2 and GCP3 based on human GCP4. Although the
two homology models appeared similar to each other, GCP3
presented a characteristic helical extension in the C-terminal,
g-tubulin-interacting domain (also known as GRIP2 domain;
Guillet et al., 2011; Gunawardane et al., 2000; Murphy et al.,
2001) (Figure 6A). Given their structural homology, unique, struc-
tured sequence insertion and the well-documented ability to het-
erodimerize, we built a dimeric model for GCP2-GCP3 and
docked it around all possible positions within the gTuRC cone.
We found that GCP2-GCP3 best fits GCP positions 1–2, 3–4,
5–6, 7–8, and 13–14 with cross-correlation scores of 0.71,
0.69, 0.70, 0.70, and 0.72, respectively (Figure 6A). Conversely,
positions 9-10 and 11-12 scored poorly (0.43 and 0.40, respec-
tively), indicating that these protomers likely contain GCP4, 5,
and 6.
To locate GCP4 in GCP positions 9, 10, 11, and 12 of the cryo-
EM map, we employed cross-correlation searches in the
constricted N-terminal region of the GCP spiral, where local res-
olution ranges from 3 to 3.5 A˚. The human GCP4 N-terminal
domain (‘‘GRIP1’’ domain, Guillet et al., 2011) extracted from
the crystal structure showed the highest correlation at GCP in po-
sitions 9 (0.62) and 11 (0.58), whereas positions 10 and 11 yielded
lower scores (0.35 and 0.41, respectively). Amino acidic side
chains of alpha helices in the crystallographic model match the
density features in the N-terminal GCP4 cryo-EM map without
the need of any real-space refinement (Figure 6B), providing us
with confidence in the subunit assignment. The rest of the atomic
structure was split in two additional domains (middle, ‘‘MID’’, and
‘‘C-terminal’’), which were docked as independent rigid bodies to
achieve the best-fitting results (Figure 6B).
To validate our homology-model-based assignment and locate
GCPsubunits5and6,weperformedCLMSanalysison thepurified
gTuRC complex. Structural interpretation of inter-protein cross-
linkswas focused on protein pairs that were crosslinkedwith three
or more residue pairs. 16 protein pairs including all 5 displayed in
Figure 6C passed this cutoff. A strong BS3 crosslink signal can
be observed between GCP2 and GCP3, supporting the notion
that the GCP2-GCP3 heterodimer is found in multiple copies
around the ring. GCP4 cross linked with GCP5 and GCP6, while
GCP6 also was observed to interact with GCP2 and GCP3ns, as indicated. Microtubules are magenta, chTOG-mGFP is green. Plots
tubule nucleation rate, and (D) themeanmicrotubule growth speed at different
er conditions: 23 pM, n = 27; 47 pM, n = 64; 93 pM, n = 96; 187 pM, n = 191; 249
-TPX2 concentrations (49, 98, 195, and 390 nM). Assays were performed in the
obilization. (E) Representative TIRFM images of gTuRC-mediated microtubule
Plots showing, (F) linearly increasing microtubule numbers over time, (G) the
t different mGFP-TPX2 concentrations. Number of microtubule growth speeds
= 143; 390 nM, n = 105.
EB3 concentrations (50, 100, 200, and 400 nM). Assays were performed in the
immobilization. (I) Representative merged TIRFM images of gTuRC-mediated
reen), as indicated. Plots showing, (J) linearly increasing microtubule numbers
growth speed at different mGFP-EB3 concentrations. Number of microtubule
n = 230; 200 nM, n = 191; 400 nM, n = 290. As controls, representative TIRFM
uRC are shown for the highest tested concentration of the various microtubule-
ere taken from the slope of the linear regression of the increase of microtubule
33C. All error bars are SEM. For symbols without visible error bars, error bars
rbitrary units. Fluorescence intensities are directly comparable. Scale bars as
d S4; Videos S6 and S7.
Table 1. Data Collection and Refinement Statistics
gTuRC Cryo-EM Data Collection and Map Refinement
Microscope Titan Krios TEM (Thermo Fisher)
Detector K2 summit (Gatan) in counting mode
Nominal magnification 130,000
Voltage (kV) 300
Electron exposure (e/A˚2) 50
Defocus range (mm) 1.0 to 3.5
Pixel size (A˚) 1.08
Symmetry C1
Initial particle images (no.) 1,100,000
Final particle images (no.) 522,496
Sharpening B-factor 100
FSC threshold 0.143
Map resolution (A˚) 4.0
Map resolution range (A˚) 3.5 to 8.5
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OPEN ACCESSArticle(Figure 6C; see also Data S2). We generated a pseudo-atomic
structure by docking homology models into the cryo-EM density
and mapped the crosslinks on our structure. The best match be-
tween the atomic model and CLMS data contains GCP5 in GCP
position 10, sandwiched between two GCP4 molecules in posi-
tions 9 and 11 and GCP6 in position 12, sandwiched between
GCP4 in position 11, and GCP2 in position 13 (Figure 6C). Only
this solution satisfies the physical constraints of the BS3 cross-
linker (all inter-GCPcrosslinksmeasure less than25 A˚ for positions
9, 10, 11, 12, and 13). Coherentwith this solution,GCP5andGCP6
MID domains display density features that are absent in GCP4, as
expected from their unique characteristic MID domain insertions.
Furthermore, GCP6 contains a unique N-terminal appendix that
can be recognized in GCP position 12 (Figures 6D and 6E). Two
crosslinks between the GCP6 and GCP3 core domains visible in
our pseudo-atomic models involve amino acids distant more
than 30 A˚ apart. The most likely interpretation is that the GCP2-
GCP3 heterodimer in positions 13-14 is highly flexible and could
come in closer proximity to GCP6, when engaged in stabilizing in-
teractions, as further addressed in the discussion section.
Peripherally Bound MZT2 and an Internal Actin Appear
to Form Stabilizing Contacts
Focusing next on the residual unoccupied density, we noted that
specific N-terminal GCP interfaces (in positions 1-2, 3-4, 5-6,
7-8, and 13-14) contacted a discernible L-shaped a-helical
feature, lining the outer perimeter of the constricted cone end
(Figure 7A). This feature appears to seal off the GCP2-GCP3
interface, occupying a position that matches that of Spc110,
required for stable gTuSC complex formation in yeast (Kollman
et al., 2015) (Figure 7B). CLMS analysis assigns this feature to
MZT2, as it crosslinks with GCP2 and GCP3 elements on the
outer perimeter of the gTuRC N-terminal constriction. Impor-
tantly, 5 of the 6 GCP2-GCP3 residues, which crosslink with
MZT2 and are visible in our pseudo-atomic model, are surface
exposed and map less than 25 A˚ away from the L-shaped
feature (Figure 7B). Conversely MZT1 crosslinks with C-terminal
GCP2, N-terminal GCP3, and N-terminal GCP6. No obvious un-
occupied features were detected in our cryo-EMmap, indicatingthat MZT1 is only flexibly tethered to the core of the gTuRC as-
sembly. On one end of the spiral, proximal to the g-tubulin
face, we could additionally observe some unassigned C-terminal
density contacting the GCP3Cterminus, whichmight function as
a cap that blocks further GCP polymerization, helping to define
subunit composition in the gTuRC complex (Figure 7A).
Additional, prominent density could also be observed within
the lumen of the gTuRC cone. Actin co-purifies with gTuRC (Fig-
ures 1C, S1B, and S1C) (Choi et al., 2010; Oegema et al., 1999).
Attempting to dock one actin protomer (PDB:2HF3 Rould et al.,
2006) into the luminal density resulted in an unambiguous fit
(cross-correlation coefficient 0.74, against a 0.49 score for a
180 rotated solution) and revealed direct contacts between
both g-tubulin and GCP3 in GCP position 2 (Figure 7C). CLMS
analysis confirmed these contacts, for example, a crosslink be-
tween GCP3 lysine 276 and actin lysine 113 maps 30 A˚ apart in
our structure, compatible with the linker length in the BS3 cross-
linking reagent (Figure 6C). Actin also interacts with one unas-
signed luminal feature, formed by a helical repeat module, which
straddles across the central pore of the helical assembly,
bridging between g-tubulin in position 2 with GCP3 in position
8 (Figure 7D). In our CLMS experiment, GCP3 crosslinked with
a GCP6 large N-terminal extension that is missing in our model.
Thus, N-terminal GCP6 is a strong candidate for the unassigned
luminal feature, coherent with a recently proposed model (Liu
et al., 2020) (Figure 6C). No obvious structural change can be de-
tected at our resolution for the actin-engaged g-tubulin.
In summary, actin and associated luminal factors, as well as
MZT2 on the outer perimeter of the assembly appear engaged
in stabilizing interactions that hold together the gTuRC spiral.
We note that gTuRC protomers in positions 1–8 match the
GCP2-GCP3 configuration in the active (‘‘closed’’) configuration
of yeast gTuSC (Kollman et al., 2015). Conversely, subunits in po-
sitions 9–14, which notably lack any stabilizing element within the
lumen, display a configuration more akin to the inactive (‘‘open’’)
form of yeast gTuSC (Kollman et al., 2015). Coherently, subunits
in positions 1–8 appear to match the geometry of a 13-subunit
microtubule protofilament and could hence sustain nucleation,
possibly starting from position 2 in the gTuRC, which presents
the first sterically available docking site on g-tubulin. The observa-
tion that gTuRC subunits in positions 9–14 markedly diverge from
microtubule geometry could justify our observation that gTuRC
enhanced microtubule nucleation is not very efficient (Video S8).
DISCUSSION
Using TIRF microscopy, we imaged the nucleation of individual
microtubules by surface-immobilized human gTuRC. Microtu-
bules were stably capped by gTuRC, not displaying any
minus-end dynamics. gTuRC increased the nucleation efficiency
comparedwithmicrotubule nucleation in solution, but nucleation
still had to overcome a significant kinetic barrier. Microtubule for-
mation on the gTuRC template was mechanistically very
different from microtubule plus-end elongation. Determining
the structure of the human gTuRC complex, using a combination
of cryo-EM and CLMS, revealed an asymmetric conformation
with half of the complex in a compact configuration (closed)
and half containing loosely interacting protomers (open). As
observed for budding yeast gTuRC (Kollman et al., 2015), theDevelopmental Cell 53, 603–617, June 8, 2020 611
Figure 5. Cryo-EM Structure of Human
gTuRC
(A) Surface rendering of the cryo-EM structure
viewed from the topand side.gTuRC isshaped like a
conewithabasediameterof 300andheight of 200 A˚.
(B) gTuRC contains 14 stalk protomers that support
14 globular densities. Subunits in the lowermost
position1and theuppermostposition14arealigned.
Docking of the human GCP4 crystal structure
(PDB:3RIP) into any of the spiral cone positions re-
veals that the 14 stalk densities correspond to GCP
proteins (position 1 is shown here as an example). A
low resolution version of the cryo-EM map is shown
to focus on the overall shape of the complex.
(C) The 14 globular densities instead correspond
to g-tubulin, as revealed by atomic docking of
PDB:1Z5V, here shown docked into position 8 as
an example. Nucleotide density (GTPgS in the
crystal structure used) is shown in red.
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OPEN ACCESS Articlerise of the helical arrangement of the g-tubulins imposes a ‘‘three
start helix’’ microtubule lattice structure with the seam being
positioned between g-tubulin 1 and 2. The human gTuRC struc-
ture is however distinctly different from the structure of budding
yeast gTuRC (Kollman et al., 2015), particularly where the GCP4,
5, and 6 subunits are located that are absent in yeast gTuRC.
Microtubule nucleation in solution has been described as a
highly cooperative process. Many tubulins need to come
together to form a first minimal stable assembly (Voter and Erick-
son, 1984). Although gTuRC is thought to nucleate microtubules
by providing a template that mimics the microtubule structure,
also nucleation from this template faced a kinetic barrier and
was highly cooperative. Our estimate of at least 7 tubulins
needing to come together before stable microtubule outgrowth
from the gTuRC complex can occur (Figure 3D) is at the lower
end of the reported range of 6–15 tubulins for such a critical nu-
cleus required for spontaneous nucleation in solution (Flyvbjerg
and Jobs, 1997; Kuchnir Fygenson et al., 1995; Voter and Erick-
son, 1984), supporting the notion that the template facilitates
nucleation.612 Developmental Cell 53, 603–617, June 8, 2020However, microtubule outgrowth from
the gTuRC template is considerably more
difficult than elongation froma pre-existing
growing microtubule plus end. Only a frac-
tion of gTuRCs nucleated within 20 min in
our assay. We did not observe any indica-
tion for a permanently inactive gTuRC
population, because the probability of sto-
chastic nucleationwas constant over time.
However, we cannot exclude that some
purified and surface-immobilized com-
plexes are permanently inactive.
Our gTuRC structure can explain the
observed inefficient nucleation. Only half
of the human gTuRC complex exists in a
closed configuration with four GCP2-
GCP3 heterodimers bound to 8 g-tubulins
being bridged together by stabilizing fac-
tors including one actin monomer in thelumen of the cone-shaped complex. Conversely, the other half
of the complex where GCP4-GCP5 and GCP4-GCP6 subunits
are located, together with one additional GCP2-GCP3 dimer at
the very top of the helical arrangement of GCP dimers, lack
bridging luminal elements and only loosely interact with one
another. This open configuration causes a g-tubulin arrangement
that deviates from themicrotubule geometry and that is expected
for an activegTuRCstate (VideoS8). This asymmetric structure in-
dicates that the purified human gTuRC is not in a fully active
conformation. Eithermicrotubule assembly on the gTuRC surface
may induce gTuRC closure and/or additional regulatory binding
factorsmay induceacompletelyclosedgTuRCgeometry required
for efficient nucleation, suggesting amechanism for the regulation
of gTuRC activity.
In favor of the scenario of microtubule assembly-induced
gTuRC closure is our observation that proteins, which stabilize
growing microtubule ends by different means and which were
shown to stimulate microtubule nucleation in vitro, also stimu-
late gTuRC-mediated microtubule nucleation. The microtubule
polymerase chTOG may do so by accelerating and thereby
Figure 6. GCP Subunit Assignment
(A) GCP2 and GCP3 are known to form a stable heterodimer. Homology modeling indicates that GCP3 contains a unique a-helical extension, resulting in a
distinctive feature that radially departs from the GCP spiral structure. This structural feature allows us to assign GCP2 and GCP3 around the gTuRC complex.
(B) GCP4 can be assign by docking the human crystal structure into the cryo-EM map. This fitting exercise, even in the absence of any further real-space
refinement, allows us to appreciate the match between amino acidic side chains from the X-ray model and the density features in the cryo-EMmap. We therefore
assignGCP4 to positions 9 and 11 in themap. Rigid-body docking of N-terminal (GRIP1) andMID-C-terminal domains (GRIP2) is required to optimize the fitting of
each individual structure. Cryo-EM density obtained with Phenix’s ResolveCryoEM is shown to highlight the fit of amino acidic side chains (central panel). The
cryo-EM density sharpened with RELION post-processing is used elsewhere in the figure.
(C) Top panel: circular representation of the CLMS results. Intra-subunit crosslinks are displayed as purple lines. Inter-subunit crosslinks are represented as green
lines. Bottom panel: inter-molecular crosslinks between GCP subunits and actin help establish the subunit order around the gTuRC spiral.
(D) GCP5 in position 10 contains a characteristic predicted helical extension in the MID domain.
(E) Assigned to position 12, GCP6 contains the largest N-terminal extension (marked in black) and MID domain insertion (marked in red) among GCP protomers.
Also see Figures S5 and S6.
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OPEN ACCESSArticlestabilizing nascent microtubule growth on gTuRC by its poly-
merase activity (Brouhard et al., 2008; Roostalu et al., 2015),
and TPX2 may do so by its catastrophe-suppressing activity
(Roostalu et al., 2015; Wieczorek et al., 2015). chTOG and
TPX2 were also reported to promote microtubule outgrowth
from stabilized microtubule ‘‘seeds,’’ suggesting similarities be-
tween outgrowth from such seeds and templating a microtu-
bule by gTuRC (Wieczorek et al., 2015). Interestingly, both
chTOG and TPX2 have also been reported to directly interactwith gTuRC, which may increase the efficiency of their action
(Alfaro-Aco et al., 2017; Thawani et al., 2018). However, we
did not observe evidence of significant binding of these pro-
teins to our passivated surfaces with specifically immobilized
gTuRC. Moreover, TPX2 has been shown to interact addition-
ally with the HAUS (Augmin) complex that promotes branched
microtubule nucleation from pre-existing microtubules in
mitotic or meiotic spindles during cell division (Alfaro-Aco and
Petry, 2017).Developmental Cell 53, 603–617, June 8, 2020 613
Figure 7. Analysis of the Unassigned Cryo-
EM Density in the gTuRC Complex
(A) Unoccupied density appears to seal off the
interface of GCP2 and GCP3, lining the outer
perimeter of the GCP spiral (marked with an or-
ange circle). A 90 tilted view highlights unassigned
density can be observed departing from the
C-terminal end of GCP3 in position 14 (shown in
red).
(B) The feature on the outer perimeter of the GCP
spiral occupies the same position observed for
Scp110 in gTuSC. CLMS identifies this feature as
MZT2, as this factor is crosslinked with residues
clustered on the outer face of the GCP2-GCP3
interface across a region of diameter smaller than
60 A˚.
(C) Two orthogonal views corresponding to addi-
tional density found in the lumen of the gTuRC
spiral. Part of this density can be assigned to actin
(magenta), which was found to be co-purified in
our preparation. Additional unassigned density
shown in gray contains three recognizable alpha
helical bundles.
(D) The luminal density bridges g-tubulin in position
2 and GCP3 in position 8. Also see Figure S6.
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OPEN ACCESS ArticleOur structure suggests a potential mechanism for the activa-
tion of human gTuRC by complex closure. In our structure, all
GCP2-GCP3 interfaces in the closed part of the complex are
sealed off by MZT2, an inter-protomer element, in a position
reminiscent of yeast gTuSC specific Spc110. As for Spc110,
we propose that MZT2 is likely required to stabilize the GCP2-
GCP3 spiral formation at the constricted N-terminal dimerization
core. At least 5 additional binding sites in the open part of the
complex remain available at inter-protomer interfaces along
the perimeter of the constricted spiral base, which could be
engaged by additional nucleation-activation factors.
These elements in the gTuRC structure suggest an activation
mechanism for human gTuRC that differs from the activation
mechanism for budding yeast gTuRC. This difference is likely a
consequence of different GCP subunit compositions of the two614 Developmental Cell 53, 603–617, June 8, 2020complexes. Yeast gTuRC consists of a he-
lical arrangement of 7 identical gTuSCs (2
g-tubulins and one GCP2 and 3 each)
and displays gaps between every second
g-tubulin (within a gTuSC) that create a
mismatch with the microtubule geometry
(Kollman et al., 2015). Consequently, in
addition to regulation at the level of com-
plex assembly by recruitment factors to
the spindle pole body, yeast gTuRC can
be further activated by a structural change
closing the gaps between the g-tubulins,
resulting in a g-tubulin arrangement that
matches the 13-mer protofilament geome-
try of the microtubule (Kollman et al.,
2015). In contrast, the human gTuRC
structure departs from themicrotubule ge-
ometry where GCP4, 5, and 6 are located,
resulting in an entire half of the complexbeing in an open conformation. It is tempting to speculate that
other proteins that may line the outer perimeter of the open part
of gTuRC (or its inner lumen) may induce a conformational
change, closing the second half of the complex and thereby pro-
ducing a completely closed conformation in which the g-tubulin
configuration closely matches the geometry of the microtubule
lattice. Such reconfigurationmay consequently reduce the kinetic
barrier for templated microtubule nucleation.
Cryo-EM structures of the human and Xenopus gTuRC com-
plex have recently been published (Liu et al., 2020; Wieczorek
et al., 2020). Overall, these structures are similar to the structure
reported here. However, some differences with the previously
published structure of the human complex can be observed.
An unidentified factor binds between subunits GCP4 and
GCP6 in positions 11 and 12, respectively (Wieczorek et al.,
ll
OPEN ACCESSArticle2020), which is absent in our structure of the complex. This factor
appears to stabilize the interaction between GCP4 and GCP6,
which display a more compact interface than in our structure,
possibly representing a partially activated complex.
Moreover, it is interesting to note that the g-tubulin used in
our docking experiment exists in a curved configuration (Aldaz
et al., 2005), different from that of tubulin dimers incorporated
in a microtubule lattice (Brouhard and Rice, 2014). Additional
conformational changes may be required for g-tubulin as a
microtubule assembles on the gTuRC template (Wieczorek
et al., 2020).
A major open question for the future will be to understand
how the various proteins involved in controlling the efficiency
of microtubule nucleation in cells control the conformation
and activity of human gTuRC. Real-time in vitro nucleation as-
says in combination with structural investigations will be
essential to shed light on the detailed mechanism of spatio-
temporal gTuRC activation, probably by an open-to-closed
transition.STAR+METHODS
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Antibodies
g-tubulin, clone GTU-88 Sigma-Aldrich Cat#: T6557; RRID: AB_477584
mTagBFP Evrogen Cat#: AB233;
RRID: AB_2571743
polyclonal rabbit anti-GCP2 antibody
(amino acids 1-155)
this study costum-made, Pettingill
polyclonal rabbit anti-GCP4 antibody
(amino acids: 1-745)
this study costum-made Covalab
mouse anti-HA, clone F-7 Santa Cruz Biotechnology Cat#: sc-7392; RRID: AB_627809
anti-rabbit WestVision Peroxidase Polymer
antibody
Vector Cat#: WB-1000; RRID: AB_2336860
goat anti-mouse immunoglobulins/HRP Agilent Cat#: P0447;
RRID: AB_2617137




rabbit anti-actin, beta polyclonal antibody Abcam Cat# ab8227;
RRID:AB_2305186
Bacterial and Virus Strains
Bacterial strain for molecular cloning:
Escherichia coli DH5a
EMBL Strain name: DH5a
Chemicals, Peptides, and Recombinant Proteins
gTuRC-GCP2-mBFP-AviTag This study Corresponding recombinant DNA: pTC069
mGFP-EB3 Previously used by Roostalu et al. (2020) N/A
mGFP-TPX2 Previously used by Roostalu et al. (2015) N/A
chTOG-mGFP Previously used by Roostalu et al. (2015) N/A
Pig brain tubulin Purified according to Castoldi and
Popov (2003)
N/A
Catalase Sigma-Aldrich Cat#: C40
Glucose Oxidase Serva Cat#: 22778.01
Bovine Serum Albumin Sigma-Aldrich Cat#: 05470
k-casein Sigma-Aldrich Cat#: C0406
NeutrAvidin LifeTechnologies Cat#: A2666
(3-Glycidyloxypropyl)trimethoxy-silane Sigma-Aldrich Cat#: 440167
Biotin-CONH-PEG-NH2 (3000 Da) Rapp Polymere GmbH Cat#: 133000-25-20
HO-PEG-NH2 (3000 Da) Rapp Polymere GmbH Cat#: 103000-20
Streptavidin-HRP Thermo Fisher Cat#: 21130
BS3 (bis(sulfosuccinimidyl)suberate) Thermo Fisher Cat#: 21586
Deposited Data
Human gTuRC This study EMD-10744
Crosslinking mass spectrometry data This study PRIDE-PXD018106
Experimental Models: Cell Lines
HeLa Kyoto cells for recombinant GCP2-
mBFP-AviTag expression
Cell services, Francis Crick Institute CVCL_1922
(Continued on next page)
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pTC069 (pLVX-Puro-GCP2-mGFP-AviTag) This study cDNA from Origene (NCBI Reference
Sequence: NM_001256617.1)
pTC070 (pLVX-IRES-Hyg-HA-BirA) This study BirA sequence taken from plasmid pJR284
Software and Algorithms
Fiji for image analysis NIH, USA https://fiji.sc/
Matlab for image alignment MathWorks https://www.mathworks.com/products/
matlab.html
RELION-3.0 Scheres, 2012; Zivanov et al., 2018 https://www2.mrc-lmb.cam.ac.uk/relion/
index.php?title=Main_Page
EMAN2 v2.07 Tang et al., 2007 https://blake.bcm.edu/emanwiki/EMAN2
Gctf v.1.18 Zhang, 2016 https://doi.org/10.1016/j.jsb.2015.11.003
MotionCor2 Zheng et al., 2017 https://msg.ucsf.edu/em/software/
motioncor2.html
crYOLO (SPHIRE Package) Wagner et al., 2019 https://msg.ucsf.edu/em/software/
motioncor2.html
cryoSPARC v2 Punjani et al., 2017 https://www.nature.com/articles/
nmeth.4169
PHENIX v1.13 Adams et al., 2010; Afonine et al., 2018;
Terwilliger et al., 2019
http://www.phenix-online.org/
UCSF Chimera Pettersen et al., 2004 https://www.cgl.ucsf.edu/chimera/
iTasser Roy et al., 2010 https://www.nature.com/articles/nprot.
2010.5
Coot v0.8.8 Emsley et al., 2010 http://scripts.iucr.org/cgi-bin/paper?
S0907444910007493
Namdinator Kidmose et al., 2019 http://journals.iucr.org/m/issues/2019/04/
00/eh5002/index.html
xiSEARCH Mendes et al., 2019 https://www.rappsilberlab.org/software/
xisearch
xiFDR Fischer and Rappsilber, 2017 https://www.rappsilberlab.org/
software/xifdr
(Continued on next page)
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Other
HiPrep 26/10 Desalting column GE Healthcare Cat#: 17508701
HiTrap Desalting column GE Healthcare Cat#: 17140801
HiTrap SP Sepharose FF column GE Healthcare Cat#: 17505401
Streptavidin mutein matrix Sigma-Aldrich Cat#: 3708152001
Superose 6 10/300 GL column GE Healthcare Cat#: 29091596
Superdex Peptide 3.2/300 column GE Healthcare N/A
Lacey grids (400 mesh) with a layer of ultra-
thin carbon
Agar Scientific Cat#: AGS187-4
50-centimetre EASY-Spray C18 LC column Thermo Scientific N/A
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Lead Contact
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact Thomas
Surrey (thomas.surrey@crg.eu).
Materials Availability
Plasmids and the cell line generated in this study are available upon request.
Data and Code Availability
The electronmicroscopymap has been deposited to the ElectronMicroscopy Data Bank under accession numbers EMD-10744. The
mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository
with the dataset identifier PXD018106.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Escherichia coli bacterial strains DH5a and DH10MultiBac were grown in Luria Bertani (LB) medium in the appropriate antibiotics.
HeLa-Kyoto cells (RRID:CVCL_1922) were cultured at 37C (10%CO2) in Dulbecco’sModified EagleMedium (DMEM) supplemented
with 10% fetal bovine serum, 50 UmL-1 penicillin and 50 mg mL-1 streptomycin. Absence of mycoplasma contamination was verified
regularly.
METHOD DETAILS
Lentivirus Expression Constructs and Molecular Biology
To generate a fluorescently-tagged and biotinylatable human gTuRC, the coding region for full-length human GCP2 (amino acids 1-
902) was amplified by PCR using its cDNA as template (NM_001256617.1, Origene). The mTagBFP (blue fluorescent protein, Evro-
gen) coding sequence was also amplified by PCR. Both PCR-amplified sequences were cloned into a pLVX-Puro vector (Clonetech)
using Gibson assembly (In-Fusion cloning, Takara), to form GCP2_G5A_TEV_G5A_mTagBFP_G5A_BAP, an expression construct for
GCP2 which is C-terminally tagged with mTagBFP and biotin acceptor peptide (BAP: GLNDIFEAQKIEWHE), both separated from
GCP2 by a TEV protease cleavage site. Glycine linkers (G5A) were placed between sequences. To facilitate the in vivo biotinylation
of tagged gTuRC E. coli biotin ligase BirA was cloned into a pLVX-IRES-Hyg vector (Clonetech) using Gibson assembly to form HA_
G5A_BirA; an expression construct of BirA with an HA-tag added to the BirA N-terminus, separated by a G5A-linker. Primers used for
cloning are listed in the Key Resources Table.
Antibodies
Commercial and custom-made antibodies were used for the characterization of purified gTuRC by western blotting (see Key Re-
sources Table). Custom-made antibodies were raised against His6-tagged proteins expressed and purified from E. coli. Specific an-
tibodies were affinity purified by standard methods using MBP-tagged proteins expressed and purified from E. coli and coupled to
CNBr-beads (GE Healthcare). The specificity of custom-made antibodies was confirmed by western blotting against human cell
lysate after RNAi depletion of target proteins for 72 h using the RNAiMAX Transfection procedure (Thermo Fisher) and the RNA oligo-
nucleotide sequences described previously (Cota et al., 2017). For detection of biotinylated proteins by western blot, peroxidase
coupled streptavidin (streptavidin-HRP, Thermo Fisher) was used.e3 Developmental Cell 53, 603–617.e1–e8, June 8, 2020
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To generate HeLa-Kyoto cells stably expressing biotinylatedmTagBFP-tagged GCP2, cells were co-transduced with GCP2 and BirA
lentivirus (Abella et al., 2016) followed by hygromycin and puromycin selection. Resistant cells expressing mTagBFP were sorted by
FACS (fluorescent assisted cell sorter) and cultured independently in 96 well plates. The isolated single-cell colonies were screened
for HA-BirA expression by immunofluorescence staining (primary antibody: mouse anti-HA (F-7, Santa Cruz Biotechnology); second-
ary antibody: goat anti-mouse-FITC (Sigma)) and then using high throughput imaging (High throughput screening facility, Francis
Crick Institute). The localisation of GCP2-mTagBFP-BAP was confirmed by live-cell fluorescence imaging using a spinning disc
confocal microscope based on a NikonTI-E frame with a 100x 1.49 N.A. Nikon objective lens (Cairn Research, Faversham, UK).
mTagBFP expressing colonies were further tested by western blotting to confirm the expression of GCP2-mTagBFP-BAP and
HA-BirA.
When producing large cell cultures for purification, three days before harvesting cells (using trypsination), D-biotin (Sigma Aldrich)
was added to a final concentration of 50 mM. Cell pellets were stored at -80C until further use.
Purification of Human gTuRC
Cells were resuspended in lysis buffer (50 mM HEPES, 150 mM KCl, 5 mM MgCl2, 1 mM EGTA, 1 mM DTT, 0.1 mM GTP, pH 7.4)
containing protease inhibitors (complete EDTA-free protease inhibitor mix, Roche) and DNAse I (10 mg ml-1, Sigma-Aldrich). Resus-
pended cells were lysed using a polytron tissue dispenser (3x90 s at 6.6x103 rpm) and lysate was clarified twice by centrifugation
(17,000xg, 15 min, 4C). Clarified lysate was filtered through three sets of filters with decreasing pore size: 1.2 mm (GE Healthcare),
0.8 mm (GE-Healthcare) and 0.45 mm (Millipore). The lysate was buffer exchanged into storage buffer (lysis buffer containing 0.02%
(vol./vol.) Brij-35) over HiPrep 26/10 desalting columns to remove D-biotin from the lysate. Protein-containing fractions were pooled,
supplemented with protease inhibitors and loaded onto a 1 mL HiTrap SP Sepharose FF column connected in tandem with 1 mL
streptavidin mutein matrix beads (Sigma Aldrich) packed into a Tricorn 5/50 column (GE-Healthcare). The streptavidin mutein matrix
column was washed with 30 mL storage buffer, 30 mL wash buffer (lysis buffer containing 200 mM KCl and 0.2% (vol./vol.) Brij-35)
and 30mL storage buffer. Proteins were elutedwith storage buffer supplementedwith 5mMD-biotin. The buffer was then exchanged
back into storage buffer using a HiTrap Desalting column. Protein-containing fractions were pooled and concentrated using Amicon
centrifugal units (MWCO 30,000, Millipore), centrifuged (17,000xg, 10 min, 4C) and separated by size exclusion chromatography
using a Superose 6 10/300 GL column. gTuRC peak fractions were pooled, concentrated, ultracentrifuged (278,088.3xg, 10 min,
4C), snap frozen and stored in liquid nitrogen. From 120 g of cell pellet typically 85 mg of tagged gTuRC were purified.
Purification of Human chTOG-mGFP, mGFP-TPX2 and mGFP-EB3
GFP-taggedmicrotubule binders were purified as described (Roostalu et al., 2015, 2020). In brief, StrepTagII-chTOG-mGFP was ex-
pressed in Sf21 cells and affinity purified using a StrepTrap HP column. After removal of the N-terminal StrepTagII by tobacco etch
virus (TEV) protease, chTOG-mGFP was further purified by size exclusion chromatography. StrepTagII-mGFP-TPX2 was expressed
in Sf21 cells and affinity purified using a StrepTrap HP column. After removal of the N-terminal StrepTagII by TEV protease, mGFP-
TPX2 was further purified by anion exchange chromatography and size exclusion chromatography. His6-taggedmGFP-EB3 was ex-
pressed in E. coli (BL21 pRIL) and affinity purified using a HiTrap Chelating column. After removal of the N-terminal His6-tag by TEV
protease, mGFP-EB3 was further purified by size exclusion chromatography.
Tubulin Purification and Labelling
Porcine brain tubulin was purified and covalently labelled with NHS-biotin (Thermo Fisher) or NHS-CF640R (Sigma-Aldrich) using
standard procedures (Castoldi and Popov, 2003; Hyman et al., 1991). CF640R-tubulin was labelled at a ratio of 0.4 fluorophores
per tubulin dimer.
LC-MS/MS Analysis of Fluorescently Tagged gTuRC
Purified gTuRC was separated by SDS-PAGE and stained using InstantBlue (Expedeon). Protein bands were excised from the gel
and analysed by the Francis Crick Institute Proteomics facility. Briefly, Tryptic peptides were analysed using a Q Exactive orbitrap
mass spectrometer coupled to an Ultimate 3000 HPLC equipped with an EasySpray nano-source (Thermo Fisher Scientific). A
one-hour method of MS1 orbitrap (60k resolution) followed by top 10 HCD MS2 (35k resolution) produced raw data files. Raw files
were analysed in MaxQuant (v1.6.0.13) against the SwissProt Homo sapiens protein database (downloaded June 2019) using the
iBAQ algorithm. The canonical GCP2 sequence was replaced with the construct sequence (GCP2-5xGly-TEV-5xGly-mBFP-
5xGly-AviTag). Variable modifications of methionine oxidation and protein N-terminal acetylation along with a fixed modification
of cysteine carbamidomethylation were selected. The proteingroups.txt file was imported in Perseus (v1.4.0.2) for data analysis. Po-
tential contaminants, reverse sequences and proteins identified by site were removed. iBAQ intensities were log2 transformed.
gTuRC-Mediated Microtubule Nucleation Assay
To studymicrotubule nucleation by gTuRC,wemodified a previous TIRFmicroscopy-based surface nucleation assaywithout gTuRC
(Roostalu et al., 2015). Flow chambers were assembled from one biotin-polyethylene glycol (PEG)-functionalized coverglass and one
poly(L-lysine)-PEG-passivated counter glass.Developmental Cell 53, 603–617.e1–e8, June 8, 2020 e4
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22 mm coverglasses (Menzel Gl€aser; #1.5) were sonicated in 3 M NaOH for 30 min, rinsed with Milli-Q water, sonicated in Piranha
solution (95-97%H2SO4/30%H2O2 (3/2 (vol./vol.))) for 45min in a fume hood, washedwithMilli-Qwater, sonicated for 5min inMilli-Q
water, and washed again in Milli-Q water. After spin-drying, sandwiches consisting of two coverglasses with (3-Glycidyloxypropyl)
trimethoxy-silane (GOPTS) (Sigma Aldrich; 440167) in between themwere kept at 75 C for 30min, left to cool for 15min before glass
sandwiches were separated. After being kept in acetone for 2 x 15 min, coverglasses were spin-dried and assembled into another
sandwich with50 mg of PEGmix (biotin-CONH-PEG-NH2 (Rapp Polymere; 133000-25-20)/HO-PEG-NH2 (Rapp Polymere; 10300-
20) (1/10 (w/w))), ensuring that the pre-functionalized sides of the glasses are on the inside of the sandwich. Sandwiches were kept at
75C overnight after removing any air from the inside of the sandwich. After separation, coverglasses were sonicated for 30 min in
Milli-Q water, washed with Milli-Q water, spin-dried and stored at 4C for a maximum of 2 months.
Poly(L-lysine)-PEG-passivated counter glass was prepared by spreading 10 mL of 2 mg/mL Poly(L-lysine)-PEG (SuSoS) between
two strips of double-sided tape (placed 5 mm apart parallel to one another) on a microscopy glass (76x26 mm, VWR, 631-1550P)
and left to dry for at least 20 min. The glass was washed with water and dried with N2.
For a microscopy assay, a flow chamber consisting of one biotin-PEG-coverglass and a poly(L-lysine)-PEG counter glass was
incubated for 10 min with 5% Pluronic F-127 (Sigma Aldrich) in MilliQ water, washed with assay buffer (AB: 80 mM PIPES, 60 mM
KCl, 1 mM EGTA, 1 mM MgCl2, 1 mM GTP, 5 mM 2-mercaptoethanol, 0.15% (w/vol.) methylcellulose (4,000 cP, Sigma-Aldrich)
1% (w/vol.) glucose, 0.02% (vol./vol.) Brij-35)) supplemented with 50 mg mL-1 k-casein (Sigma-Aldrich), followed by a 3-min incuba-
tion with the same buffer additionally containing 50 mg mL-1 of NeutrAvidin (Life Technologies). The chamber was subsequently
washed with gTuRC storage buffer and incubated for 5 min with prediluted gTuRC in gTuRC storage buffer to the concentration indi-
cated for each experiment. Unbound gTuRC was removed by washing the flow cell with AB. Then the final assay mix was passed
through, the chamber was sealed with vacuum grease (Beckman) and placed onto the microscope.
Final assay mix: AB supplemented with oxygen scavengers (160 mg mL-1 catalase (Sigma-Aldrich), 680 mg mL-1 glucose oxidase
(Serva)) diluted in BRB80 (80mM PIPES, 1mM EGTA, 1mMMgCl2), 1 mg ml
-1 bovine serum albumin (Sigma-Aldrich) in BRB80, vary-
ing concentrations of tubulin (containing 4.8%CF640R-labelled tubulin). For experiments with microtubule binders 2.9% (vol./vol.) of
either chTOG-mGFP, mGFP-TPX2 or mGFP-EB3 was added at different concentrations. chTOG-mGFP and mGFP-TPX2 concen-
trations were altered by predilution in their storage buffers (Jha et al., 2017; Roostalu et al., 2015). mGFP-EB3 was diluted in BRB80.
The final assaymix containing chTOG-GFPwas ultracentrifuged (278,088.03xg, 10min, 4C) before flowing themix into the chamber.
To keep the buffer composition of the final assay mix unchanged within a set of experiments and to allow for direct comparisons
between experiments, the overall BRB80 and storage buffer content was kept constant within one set of experiments.
Microtubule Dynamics Assays Using ’Seeds’
To image the properties of microtubules having both dynamic plus and minus ends, microtubules were grown from pre-polymerized
and immobilized GMPCPP-stabilized microtubules (’seeds’). Dynamics assays were performed as nucleation assays, but instead of
gTuRC biotinylated and fluorescently labelled microtubule seeds were bound to the glass surface. Seeds were prepared as
described previously (Bieling et al., 2010), here containing 39% CF640R-labelled tubulin.
In brief, 6.7 mM tubulin, 5 mM biotinylated tubulin and 7.1 mM CF640R-labelled tubulin and 0.5 mM GMPCPP (Jena bioscience,
NU-405S) in BRB80 was incubated for 1 h at 37C, diluted 8.33-fold with prewarmed BRB80 and centrifuged at 17,000 g at room
temperature for 10 min. The pellet was resuspended in prewarmed BRB80 and centrifuged at 17,000 g for 2 min, followed again
by resuspension of the pellet in prewarmed BRB80. Microtubule seeds were kept at room temperature and used on the same day.
TIRF Microscopy
All experiments were performed using a total internal reflection fluorescence (TIRF) microscope (Cairn Research, Faversham, UK)
(Hannabuss et al., 2019). Experiments were imaged 2 min after placing the chamber on the microscope. The temperature was
kept at 33±1C for all experiments. Two- and three-colour time-lapse imaging for gTuRC nucleation assays and dynamics assays
were performed at 1 frame/5 s with a 300-ms exposure time for tubulin (640 nm) and GFP (480 nm) channels and 1000-ms for
gTuRC-mBFP (408 nm) using a 60x 1.49 NA Nikon objective lens. For single molecule gTuRC assays shown in Figure 2F, images
were acquired at 1 frame/1.8 s with a 500-ms exposure time using a 100x 1.49 N.A. Nikon objective lens. CF640R-tubulin
(640 nm excitation) and mGFP-tagged proteins (488 nm excitation) were imaged simultaneously. gTuRC-mTagBFP-BAP (405 nm
excitation) was imaged every 10 frames for single molecule gTuRC assays and once at the beginning and at the end of the movie
for gTuRC nucleation assays.
TIRF Microscopy Image Processing
The Fiji package of ImageJwas used to generate kymographs (space-time plots) and tomerge image sequences from different chan-
nels. For multi-colour imaging, image alignment was performed using a Matlab script (Maurer et al., 2014). Background was sub-
tracted using the background subtraction tool of Fiji (‘rolling ball’ method). For movies from single molecule gTuRC assays shown
in Figure 2F gTuRC-mTagBFP-AviTag images were merged using the ‘grouped Z project’ function in Fiji. To subtract camera noise
an empty flow chamber was imaged using the same imaging conditions. The background image was generated as described above
and subtracted from the gTuRC-mTagBFP-AviTag image, which was then used to merge with images of CF640R-tubulin.e5 Developmental Cell 53, 603–617.e1–e8, June 8, 2020
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Growth speeds were measured directly from kymographs using the ‘Resclice function’ in Fiji. Lines were drawn manually along
growing plus- and minus-ends. Growth speeds were calculated from the slope of the line. The total number of microtubules used
for the measurement of growth speeds for each experimental condition is stated in the corresponding figure legend and data was
pooled from at least three independent experiments if not stated otherwise. For conditions with high nucleation rates, at least 50 mi-
crotubules per experimental repeat were analysed. For condition with low nucleation rates, all microtubules with a minimum lifetime
of 2 min were used for analysis.
Microtubule Nucleation Rate Analysis
For each nucleation assay, microtubules were counted manually at 10 different time points either until the end of the movie or until
individual microtubule nucleation events could no longer be identified due to overcrowding. The total number of nucleated microtu-
bules in a field of view at a given time point was obtained by counting the newly nucleated microtubules and adding it to the number
obtained at the previous analysed time point. Microtubule numbers were tracked using the ‘Point tool’ together with the ‘ROI man-
ager tool’ in Fiji. For the quantification of gTuRC-mediated microtubule nucleation rates, only microtubules were counted that started
nucleating from the surface and that stayed surface-attached. Microtubule nucleation rates represent the slope of the linear regres-
sion for each condition and are given in number per nucleated microtubules per field of view and per time.
Negative Stain Grid Preparation and Data Collection
A 4-ml droplet of human gTuRC (purified as described above) diluted in gTuRC storage buffer was applied to a freshly glow-dis-
charged carbon-coated grid (C300Cu100, EM Resolution) and incubated for 2 min. The grid was stained with consecutive applica-
tions onto three 50-ml droplets of 2% uranyl acetate solution for 30 s each. The grid was then blotted dry and stored until imaged on a
120 keV G2 Spirit transmission electron microscope (FEI) equipped with a 2k32k Ultrascan-1000 camera (Gatan). The Micrographs
were collected using a nominal magnification of 30,000x, resulting in a pixel size of 3.45 A˚ at the specimen level.
Cryo Grid Preparation and Data Collection
Freeze-thawed human gTuRC (purified as described above) was briefly spun to remove aggregates. Lacey grids (400 mesh) with a
layer of ultra-thin carbon (Agar Scientific) were glow-discharged at 45 mA for 1 min using a K100X Glow Discharge Unit (EMS). A 4 ml-
droplet was then applied directly onto the carbon-side of the grid loaded into the humidity chamber of a Vitrobot Mark IV (Thermo
Fisher) set to room temperature and 90% humidity. After an incubation time of 60 seconds, the grid was blotted for 3s and plunged
into liquid ethane. The ice quality was assessed on a 200 kV Talos Arctica (Thermo Fisher) and a small dataset was collected to eval-
uate the sample quality.
The highest-quality grid was imaged using a 300kV Titan Krios electron microscope (Thermo Fisher) using a GIF Quantum energy
filter (Gatan) and a K2 Summit direct detector (Gatan), operated in counting mode. A total of 2,4000 movies were collected over two
sessions at a pixel size of 1.08 A˚/px with a total dose of 50 e/A2 and a defocus range of -1.0 - -3.5 mm.
Negative Stain Electron Microscopy Image Processing
The particles were picked using e2boxer.py of the EMAN2 v2.07 software package (Tang et al., 2007), using the semi-automated
(swarm) option. Box files were then imported in the RELION-3.0 (Zivanov et al., 2018), which was used for all downstream image
processing steps that were performed. Contrast transfer function parameters were determined using Gctf v.1.18 (Zhang, 2016),
and extracted particles were subjected to two-dimensional classification.
Cryo-EM Image Processing
To correct for beam-induced movements all movie frames were aligned using dose-weighted averaging in MotionCor2(Zheng et al.,
2017). CTF parameters were estimated using non-dose-weighted micrographs generated by Gctf v.1.18 (Zhang, 2016). Automated
particle-picking was performed using crYOLO of the SPHIRE software package (Wagner et al., 2019). Box files were imported in RE-
LION-3 (Zivanov et al., 2018) and a total of  1.1 million particles were initially binned by a factor of four and extracted from dose-
weighted micrographs with a box size of 128 pixels. After several rounds of two-dimensional classification, a total of 522,496
high-resolution particles were selected, which evidently contained high-resolution information. Unbinned particles were re-ex-
tracted, using a 512-pixel box size. These particles were used to generate three reference free ab initio models using cryoSPARC
v2 (Punjani et al., 2017). The best model, which resulted from 229,744 particles, was imported in RELION-3, filtered to 60 A˚ and
used as a starting reference for 3D classification of the 522,496 high-resolution particles. The combination of all particles yielded
in the highest resolution class, whichwas subsequently subjected to one initial 3D refinement, followed by three rounds of CTF refine-
ment and one Bayesian particle polishing step. Polished particles were subjected to one final round of CTF refinement, 3D refinement
and post processing, yielding in a final 3D structure with an overall resolution of 4 A˚. Further cryoEM density modification imple-
mented in Phenix (Terwilliger et al., 2019) increased the resolution to 3.7 A˚ (used for display in figures showing amino acid chains).
Although BFP was present in the complex, fused to the C-terminus of GCP2, density for this tag was not visible in the cryo-EM struc-
ture, due to both flexibility and the mixture of tagged and untagged GCP2 found in the complex.Developmental Cell 53, 603–617.e1–e8, June 8, 2020 e6
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The crystal structure of human GCP4 (PDB entry 3RIP) (Guillet et al., 2011) was separated in three distinct domains and used for
docking into the cryo-EMmap, using the Fit inmap option in UCSFChimera (Pettersen et al., 2004). Highest correlation GCP subunits
were assigned to GCP4, while GCP3 was recognised because of a characteristic helical extension in the C-terminal g-tubulin inter-
acting domain, first modelled using iTasser (Roy et al., 2010), adjustedmanually in Coot (Emsley et al., 2010) and refined using Phenix
(Afonine et al., 2018) and Namdinator (Kidmose et al., 2019). Other GCP assignments were based on CLMS results (detailed below).
Crosslinking and Mass Spectrometry
The purified gTuRC complex at a concentration of 0.2 mg/ml in gel filtration buffer (50 mMHEPES pH 7.4, 150 mMKCl, 1 mMMgCl2,
1 mM EGTA, 1 mM DTT, 0.1 mM GTP and 0.02 % Brij-35) was crosslinked with 2.4 mM disulfosuccinimidyl suberate (BS3) in a ther-
momixer for 1 h at 24C and 850 rpm. The reaction was quenched with 92 mM NH4HCO3 in a thermomixer for 30 min at 24C and
850 rpm. The crosslinked sample was cold-acetone precipitated. The dried protein pellet was resolubilized in 40 mL digestion buffer
(8M urea in 100 mM ammonium bicarbonate (ABC) with 1 mMDithiothreitol (DTT)) to an estimated protein concentration of 1 mg/mL.
Dissolved protein sample was reduced by addition of 0.2 uL 1M DTT, the reduction reaction was incubated at room temperature for
30 minutes. The free -SH groups in the sample were then alkylated by adding 1.2 uL 500 mM Iodoacetamide (IAA) and incubating at
room temperature for 20 minutes. After alkylation, 0.2 uL 1MDTT was added to quench excess of IAA. Subsequently, protein sample
was digested with LysC (with 1:50 (m/m) protein to protease ratio) at room temperature for four hours. The sample was then diluted
with 100 mM ABC to reach urea concentration of 1.5 M. Trypsin was added with 1:50 (m/m) protein to protease ratio to further digest
proteins for over night (15 hours) at room temperature. Resulting peptides were de-salted using C18 StageTips (PMID:17703201).
20% of total peptides were directly analysed by liquid chromatography–tandemmass spectrometry (LC-MS/MS) in duplicate. The
remaining 80% peptides were fractionated using size exclusion chromatography in order to enrich for crosslinked peptides
(PMID:24356771). Peptides were separated using a Superdex Peptide 3.2/300 column (GE Healthcare) at a flow rate of 10 ml/min.
The mobile phase consisted of 30% (v/v) acetonitrile and 0.1% trifluoroacetic acid. The earliest six peptide-containing fractions
(50 ml each) were collected. Solvent was removed using a vacuum concentrator. The fractions were then analysed by LC-MS/MS.
LC-MS/MS analysis was performed using an Orbitrap Fusion Lumos Tribrid mass spectrometer (Thermo Fisher Scientific), con-
nected to an Ultimate 3000 RSLCnano system (Dionex, Thermo Fisher Scientific). Each SEC fraction was resuspended in 1.6% v/
v acetonitrile 0.1% v/v formic acid and analysed with two LC-MS/MS acquisitions. Peptides were injected onto a 50-centimetre
EASY-Spray C18 LC column (Thermo Scientific) that is operated at 50C column temperature. Mobile phase A consists of water,
0.1% v/v formic acid and mobile phase B consists of 80% v/v acetonitrile and 0.1% v/v formic acid. Peptides were loaded and sepa-
rated at a flowrate of 0.3 mL/min. Eluted peptides were ionized by an EASY-Spray source (Thermo Scientific) and introduced directly
into the mass spectrometer.
For non-fractionated samples, peptides were separated using a linear gradient going from 2% mobile phase B to 40% mobile
phase B over 110minutes, followed by a linear increase from 40% to 95%mobile phase B in elevenminutes. TheMS data is acquired
in the data-dependent mode with three-second acquisition cycle. The full scan mass spectrum was recorded in the Orbitrap with a
resolution of 120,000. The ions with a charge state from 3+ to 7+ were isolated and fragmented using higher-energy collisional disso-
ciation (HCD) with 30% collision energy. The fragmentation spectra were then recorded in the Orbitrap with a resolution of 50000.
Dynamic exclusion was enabled with single repeat count and 60-second exclusion duration.
The collected SEC fractions were each analysed with duplicated acquisitions. Peptides were separated by applying a gradient
ranging from 2% to 45% B over 90 min. Gradient was optimized for each corresponding SEC fraction. Following the separating
gradient, the content of B was ramped to 55% and 95% within 2.5 minutes each. The MS data is acquired in the data-dependent
mode with the top-speed option. For each three-second acquisition cycle, the full scan mass spectrum was recorded in the Orbitrap
with a resolution of 120,000. The ions with a charge state from 3+ to 7+ were isolated and fragmented using Higher-energy collisional
dissociation (HCD). For each isolated precursor, one of three collision energy settings (26%, 28% or 30%) was selected for fragmen-
tation using data dependent decision tree based on the m/z and charge of the precursor. The fragmentation spectra were then re-
corded in the Orbitrap with a resolution of 50000. Dynamic exclusion was enabled with single repeat count and 60-second exclusion
duration.
The MS2 peak lists were generated from the raw mass spectrometric data files using the MSConvert module in ProteoWizard
(version 3.0.11729). The default parameters were applied, except that TopMS/MSPeaks per 100Dawas set to 20 and the de-noising
function was enabled. Precursor and fragment m/z values were recalibrated. Identification of crosslinked peptides was carried out
using xiSEARCH software (https://www.rappsilberlab.org/software/xisearch) (PMID:31556486). Peak lists from all LC-MS/MS acqui-
sitions were searched against the sequence and the reversed sequence of gTuRC subunits. The following parameters were applied
for the search: MS accuracy = 5 ppm; MS2 accuracy = 10 ppm; enzyme = trypsin (with full tryptic specificity); allowed number of
missed cleavages = two; missing monoisotopic peak=2 5; cross-linker = BS3 the reaction specificity for BS3 was assumed to be
for lysine, serine, threonine, tyrosine and protein N termini); fixed modifications = carbamidomethylation on cysteine; variable mod-
ifications = oxidation onmethionine, modifications by BS3 that are hydrolyzed or amidated on the end. Identified crosslinked peptide
candidates were filtered using XiFDR (PMID: 28267312). A false discovery rate (FDR) of 2% on residue-pair-level was applied with
‘‘boost between’’ option selected. A list of identified crosslinked residue pairs is reported in Data S2. Structural interpretation of inter-
protein crosslinks was focused on protein pairs that were crosslinked with three or more residue pairs. The pseudo-atomic model of
gTuRC complexwas compared against the crosslinking data. The distances between theCa atoms of crosslinked residue pairs in thee7 Developmental Cell 53, 603–617.e1–e8, June 8, 2020
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of the crosslinker and the length of the side chains of crosslinked residues).
QUANTIFICATION AND STATISTICAL ANALYSIS
Image analysis was performed with the Fiji package of ImageJ and Matlab. Plots were generated in GraphPad Prism. Data were
pooled from at least three independently performed experiments if not stated otherwise. All error bars represent the standard error
of mean (s.e.m.) or standard deviation (s.d.) as indicated in each Figure. Linear regression and curve fitting were performed using
GraphPad Prism. Details of the analysis are given in the STAR Methods DETAIL section.Developmental Cell 53, 603–617.e1–e8, June 8, 2020 e8
